News

Is a Pfizer-AstraZeneca merger in the offing?

Grant Hodgkins, ex of Alcon Labs, joins Jay Crowley, ex-FDA senior advisor, at the firm

A potential unintended consequence of the Physicians Sunshine Act: Some job-candidate interviews will become a publicly accessible record

Annual IMS Institute survey finds generics level at 86%

Enhanced reuse could be possible with ProEnvision system

Temptime will partner with Thin Film Electronics ASA to commercialize

Innovation award goes to Mem-O-Ring, a pill-bottle attachment

Leading pharma market-data provider returns to public equity investment

Mexico, Brazil and Chile will see new or expanded healthcare logistics capability

First of many meetings to come that are required by the Drug Supply Chain Security Act

Fast-tracked product is acclaimed by FDA as well as its developer, Kaleo

Moffitt's M2Gen subsidiary provides access to patient histories, biospecimens

Pharmaceutical Commerce's latest report finds continued growth in these specialized logistics services

Voluntary recall of all products in the US and Puerto Rico has begun

Pharma companies assess their ongoing reporting capabilities

Annual survey tracks rapid evolution in a critical pharma market

Expanded cold-chain storage, more office space is driven by 40% business growth

Company also announces a 10-year agreement with Salesforce.com

Researchers suggest that the surge in analysis of large data sets may have limitations for understanding healthcare patterns

Award was earned at 2014 BioPharma Asia meeting in Singapore

Clinical Trials Supply Chain Solutions (CTSCS) becomes Clinical Supply Solutions (CSS)

Cost-cutting will continue while marketplace demands a higher level of data quality from pharma

Newly branded company is one of the largest contract development and manufacturing organizations (CDMOs) in the world

Procurement-automation platform could grow beyond its hospital-products roots

Service connects McKesson industry clients to PI's network of e-prescribing and EHRs

Pharma industry is invited into some EHRs, excluded from others

Industry appears to be realigning spending ahead of the Sunshine Act

New reasons why the announced death of this profession will always be premature